Arecor Therapeutics PLC to Announce Orderly Cessastion of Tetris Pharma and Mutual Agreement with Xeris Presentation Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Julie Simmonds - Panmure Liberum - Analyst : (technical difficulty) the wind-down of the process. So when it actually sort of all kicks off?

Question: Julie Simmonds - Panmure Liberum - Analyst : Sure. I was wondering how long it's going to take to sort of start the process and sort of when we should be thinking that the Tetris revenue stops and then also how the impact this has on working capital because clearly, that's been one of the biggest issues at Tetris in recent years?

Question: Edward Sham - Singer Capital Markets - Analyst : It's just probably a follow-up question from Julie. In terms of the wind-down of operations, is there much restructuring costs in terms of that staff that you hold within Tetris and how that might sort of -- will there be some sort of -- will the employees join over from Tetris and join the Arecor team? Or what kind of will happen sort of moving forward if you don't mind me asking? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JANUARY 10, 2025 / 8:45AM, AREC.L - Arecor Therapeutics PLC to Announce Orderly Cessastion of Tetris Pharma and Mutual Agreement with Xeris Presentation

Question: Edward Sham - Singer Capital Markets - Analyst : Perfect. That's really helpful. And then maybe just on the sort of the wind-down of Tetris again. Was there not a possibility to potentially sell those rights to someone else?